This continuing professional development (CPD) supplement focuses on the regulatory framework available to drug developers for expediting their products’ development and review processes in the EU and US. These mechanisms are relevant for products which address an unmet medical need in the treatment of a serious and/or life-threatening condition.
Five great reasons to become a TOPRA member:
Have you heard? Why not listen to one of our free podcasts to see what you’re missing?